A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction

被引：0
|
作者：
Ali A. Siddiqui
Devi Patel
Jeremy Kaplan
Andrew H. Zabolotsky
David Loren
Thomas Kowalski
Saad S. Ghumman
Douglas G. Adler
Satish Munigal
Umar Hayat
Mohamad A. Eloubeidi
机构：
[1] Thomas Jefferson University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[2] University of Utah,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[3] Washington University School of Medicine,Department of Internal Medicine
[4] Northeast Alabama Regional Medical Center,Division of Gastroenterology
来源：
Digestive Diseases and Sciences | 2015年 / 60卷
关键词：
Acute pancreatitis; Endoscopic retrograde cholangiopancreatography; Indomethacin; Sphincter of Oddi dysfunction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2509 / 2515
页数：6
相关论文
共 50 条
  • [21] EFFICACY OF RECTAL INDOMETHACIN IN PREVENTION OF POST-ERCP PANCREATITIS
    Fatima, Hina
    Hussain, Mudassar
    Akhtar, Ziyad Humayun
    Raja, Ikram Ul Haq
    Ali, Bushra
    Nawaz, Arif Amir
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 12068 - 12073
  • [22] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis (vol 367, pg 277, 2012)
    Abu Dayyeh, Barham K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (11): : 1073 - 1073
  • [23] Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis
    Singh, P
    Gurudu, SR
    Davidoff, S
    Sivak, MV
    Indaram, A
    Kasmin, FE
    Nozdak, V
    Wong, RCK
    Isenberg, G
    Stark, B
    Bank, S
    Chak, A
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (04) : 499 - 505
  • [24] A novel method to reduce post-ERCP pancreatitis in patients with sphincter of Oddi dysfunction: Botulinum toxin injection of the residual pancreatic sphincter
    Gorelick, AB
    Barnett, JL
    Chey, WD
    Elta, GH
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) : AB239 - AB239
  • [25] Early Measures of Hemoconcentration and Inflammation Are Predictive of Severe Post-ERCP Pancreatitis (PEP) Among Patients With Suspected Sphincter of Oddi Dysfunction Undergoing Manometry
    Cote, Gregory A.
    Schmidt, Suzette E.
    Imperiale, Thomas E.
    Fogel, Evan L.
    Lehman, Glen A.
    McHenry, Lee
    Watkins, James I.
    Sherman, Stuart
    GASTROENTEROLOGY, 2011, 140 (05) : S383 - S383
  • [26] Pancreatic duct (PD) stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction (SOD) but normal manometry (SOM)
    Saad, Abdo M.
    Fogel, Evan L.
    McHenry, Lee
    Watkins, James L.
    Sherman, Stuart
    Lazzell-Pannell, Laura
    Lehman, Glen A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S113 - S114
  • [27] Pre-Procedure BUN and Hct as Predictors of Post-ERCP Pancreatitis (PEP) Among Patients With Suspected Sphincter of Oddi Dysfunction Undergoing Manometry
    Cote, Gregory A.
    Schmidt, Suzette E.
    Imperiale, Thomas E.
    Fogel, Evan L.
    Lehman, Glen A.
    McHenry, Lee
    Watkins, James L.
    Sherman, Stuart
    GASTROENTEROLOGY, 2011, 140 (05) : S382 - S382
  • [28] Can rectal NSAIDs prevent post-ERCP pancreatitis?
    Pier Alberto Testoni
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 429 - 430
  • [29] Can rectal NSAIDs prevent post-ERCP pancreatitis?
    Testoni, Pier Alberto
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) : 429 - 430
  • [30] Effect of Rectal Indomethacin and/or Pancreatic Stents to Prevent Post-ERCP Pancreatitis: Post-Hoc Analysis of a Randomized Controlled Trial
    Levenick, John M.
    Gordon, Stuart R.
    Gardner, Timothy
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB272 - AB272
12345